Enanta Pharmaceuticals Inc (ENTA)
12.43
-0.05
(-0.40%)
USD |
NASDAQ |
Apr 26, 11:02
Enanta Pharmaceuticals Shareholders Equity (Quarterly): 191.88M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 191.88M |
| September 30, 2023 | 216.74M |
| June 30, 2023 | 237.82M |
| March 31, 2023 | 269.38M |
| December 31, 2022 | 300.84M |
| September 30, 2022 | 321.33M |
| June 30, 2022 | 338.02M |
| March 31, 2022 | 358.58M |
| December 31, 2021 | 384.38M |
| September 30, 2021 | 399.43M |
| June 30, 2021 | 417.85M |
| March 31, 2021 | 436.03M |
| December 31, 2020 | 452.00M |
| September 30, 2020 | 455.58M |
| June 30, 2020 | 480.56M |
| March 31, 2020 | 485.99M |
| December 31, 2019 | 482.29M |
| September 30, 2019 | 462.49M |
| June 30, 2019 | 448.10M |
| March 31, 2019 | 436.21M |
| December 31, 2018 | 426.84M |
| September 30, 2018 | 393.68M |
| June 30, 2018 | 360.90M |
| March 31, 2018 | 333.40M |
| Date | Value |
|---|---|
| December 31, 2017 | 317.58M |
| September 30, 2017 | 301.68M |
| June 30, 2017 | 260.87M |
| March 31, 2017 | 266.01M |
| December 31, 2016 | 268.17M |
| September 30, 2016 | 269.94M |
| June 30, 2016 | 269.01M |
| March 31, 2016 | 266.42M |
| December 31, 2015 | 264.28M |
| September 30, 2015 | 236.16M |
| June 30, 2015 | 228.28M |
| March 31, 2015 | 224.22M |
| December 31, 2014 | 193.71M |
| September 30, 2014 | 148.65M |
| June 30, 2014 | 152.95M |
| March 31, 2014 | 101.72M |
| December 31, 2013 | 105.58M |
| September 30, 2013 | 110.47M |
| June 30, 2013 | 114.41M |
| March 31, 2013 | 118.38M |
| December 31, 2012 | 66.22M |
| September 30, 2012 | 43.93M |
| June 30, 2012 | -110.25M |
| September 30, 2011 | 21.95M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
191.88M
Minimum
Dec 2023
485.99M
Maximum
Mar 2020
375.75M
Average
399.43M
Median
Sep 2021
Shareholders Equity (Quarterly) Benchmarks
| Madrigal Pharmaceuticals Inc | 405.33M |
| Galectin Therapeutics Inc | -60.24M |
| Viking Therapeutics Inc | 933.89M |
| Akero Therapeutics Inc | 535.31M |
| 89bio Inc | 536.31M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 428.50M |
| Total Liabilities (Quarterly) | 236.62M |
| Current Ratio | 6.254 |